Trial Profile
PEG-asparaginase During Two Treatment Courses in the Treatment of Childhood Acute Lymphoblastic Leukemia.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Pegaspargase (Primary) ; Asparaginase
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 24 Mar 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 02 Dec 2005 New trial record.